New Treatment for Rare Lymphoma with Immunotherapy
Gray zone lymphoma, a rare form of lymphoma could respond to immunotherapy using checkpoint inhibitors, according to three case reports, one from University of Colorado Cancer Center using nivolumab, and two from the National Institutes of Health using pembrolizumab. Recent case reports have suggested that treatment with checkpoint inhibitors such as nivolumab, pembrolizumab may be effective in gray zone lymphoma.
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer